| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698297 | Clinical Oncology | 2016 | 6 Pages |
Abstract
The toxicity for this radiobiological guided dose-painting protocol was low, but we have only treated a small cohort with limited follow-up time. The advantages of this treatment approach should be established in a clinical trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Uzan, A.E. Nahum, I. Syndikus,